ETHYL GLUCURONIDE: A BIOMARKER TO IDENTIFY ALCOHOL USE BY HEALTH PROFESSIONALS RECOVERING FROM SUBSTANCE USE DISORDERS | Zendy

Gregory E. Skipper | Zendy; Wolfgang Weinmann | Zendy; Annette Thierauf | Zendy; Patrick M. Schaefer | Zendy; Gerhard A. Wiesbeck | Zendy; John P. Allen | Zendy; Michael J. Miller | Zendy; Friedrich Martin Wurst | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

ETHYL GLUCURONIDE: A BIOMARKER TO IDENTIFY ALCOHOL USE BY HEALTH PROFESSIONALS RECOVERING FROM SUBSTANCE USE DISORDERS

Author(s) -

Gregory E. Skipper,

Wolfgang Weinmann,

Annette Thierauf,

Patrick M. Schaefer,

Gerhard A. Wiesbeck,

John P. Allen,

Michael J. Miller,

Friedrich Martin Wurst

Publication year - 2004

Publication title -

alcohol and alcoholism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.747

H-Index - 99

eISSN - 1464-3502

pISSN - 0735-0414

DOI - 10.1093/alcalc/agh078

Subject(s) - ethyl glucuronide , medicine , urine , abstinence , alcohol , substance abuse detection , alcohol dependence , psychiatry , biomarker , urinalysis , alcohol consumption , biochemistry , chemistry

Physicians recovering from substance-related disorders are usually allowed to return to practice if they agree to remain abstinent from drugs, including alcohol, and to undergo random urine testing. Over 9000 physicians are currently involved in such monitoring programs in the US. To date, it has been difficult to adequately monitor abstinence from alcohol due to the short half-life of alcohol and no other highly specific marker. Ethyl glucuronide (EtG), a direct metabolite of alcohol, offers an extended window for assessment of drinking status (up to 5 days). Our aim was to assess the potential value of EtG testing in abstinence-based monitoring programs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research